From 2006-2010, 140 new molecular entities (NMEs) were launched by pharma companies. On Page 16 of the hyperlinked report above, IMS compared which countries had the most avaialbility of these NMEs by 2011. The USA fared best.
Last updated: October 26th, 2022
